Keybanc Maintains Overweight on Progyny, Raises Price Target to $35

Progyny

Progyny

PGNY

0.00

Keybanc analyst Scott Schoenhaus maintains Progyny (NASDAQ: PGNY) with a Overweight and raises the price target from $30 to $35.